Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>FL R/R EZH2+ > TREAT.: > USA. E. Tazemetostat Tablets



USA. E. Tazemetostat Tablets's subsections
(*) USA Approval Date: 2020. 06.18.
>Treat.>2 Prior Medicines
Companion Diagnostics>
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 5
Patent>UpDate: 2020. 09.22.
TradeMark
TradeMark Web-Site

USA. E. Tazemetostat Tablets's products
This section has no products